Literature DB >> 27915094

Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals.

Mira Kharbanda1, Daniela T Pilz2, Susan Tomkins3, Kate Chandler4, Anand Saggar5, Alan Fryer6, Victoria McKay6, Pedro Louro7, Jill Clayton Smith4, John Burn8, Usha Kini9, Anna De Burca9, David R FitzPatrick10, Esther Kinning2.   

Abstract

Loss of function mutations in CTNNB1 have been reported in individuals with intellectual disability [MIM #615075] associated with peripheral spasticity, microcephaly and central hypotonia, suggesting a recognisable phenotype associated with haploinsufficiency for this gene. Trio based whole exome sequencing via the Deciphering Developmental Disorders (DDD) study has identified eleven further individuals with de novo loss of function mutations in CTNNB1. Here we report detailed phenotypic information on ten of these. We confirm the features that have been previously described and further delineate the skin and hair findings, including fair skin and fair and sparse hair with unusual patterning.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CTNNB1; Intellectual disability; Microcephaly

Mesh:

Substances:

Year:  2016        PMID: 27915094      PMCID: PMC6070129          DOI: 10.1016/j.ejmg.2016.11.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

1.  beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin.

Authors:  J Huelsken; R Vogel; B Erdmann; G Cotsarelis; W Birchmeier
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

2.  De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.

Authors:  Alma Kuechler; Marjolein H Willemsen; Beate Albrecht; Carlos A Bacino; Dennis W Bartholomew; Hans van Bokhoven; Marie Jose H van den Boogaard; Nuria Bramswig; Christian Büttner; Kirsten Cremer; Johanna Christina Czeschik; Hartmut Engels; Koen van Gassen; Elisabeth Graf; Mieke van Haelst; Weimin He; Jacob S Hogue; Marlies Kempers; David Koolen; Glen Monroe; Sonja de Munnik; Matthew Pastore; André Reis; Miriam S Reuter; David H Tegay; Joris Veltman; Gepke Visser; Peter van Hasselt; Eric E J Smeets; Lisenka Vissers; Thomas Wieland; Willemijn Wissink; Helger Yntema; Alexander Michael Zink; Tim M Strom; Hermann-Josef Lüdecke; Tjitske Kleefstra; Dagmar Wieczorek
Journal:  Hum Genet       Date:  2014-10-19       Impact factor: 4.132

3.  Diagnostic exome sequencing in persons with severe intellectual disability.

Authors:  Joep de Ligt; Marjolein H Willemsen; Bregje W M van Bon; Tjitske Kleefstra; Helger G Yntema; Thessa Kroes; Anneke T Vulto-van Silfhout; David A Koolen; Petra de Vries; Christian Gilissen; Marisol del Rosario; Alexander Hoischen; Hans Scheffer; Bert B A de Vries; Han G Brunner; Joris A Veltman; Lisenka E L M Vissers
Journal:  N Engl J Med       Date:  2012-10-03       Impact factor: 91.245

4.  A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency.

Authors:  Estelle Dubruc; Audrey Putoux; Audrey Labalme; Christelle Rougeot; Damien Sanlaville; Patrick Edery
Journal:  Am J Med Genet A       Date:  2014-03-25       Impact factor: 2.802

5.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development.

Authors:  V Brault; R Moore; S Kutsch; M Ishibashi; D H Rowitch; A P McMahon; L Sommer; O Boussadia; R Kemler
Journal:  Development       Date:  2001-04       Impact factor: 6.868

6.  Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.

Authors:  Valter Tucci; Tjitske Kleefstra; Andrea Hardy; Ines Heise; Silvia Maggi; Marjolein H Willemsen; Helen Hilton; Chris Esapa; Michelle Simon; Maria-Teresa Buenavista; Liam J McGuffin; Lucie Vizor; Luca Dodero; Sotirios Tsaftaris; Rosario Romero; Willy N Nillesen; Lisenka E L M Vissers; Marlies J Kempers; Anneke T Vulto-van Silfhout; Zafar Iqbal; Marta Orlando; Alessandro Maccione; Glenda Lassi; Pasqualina Farisello; Andrea Contestabile; Federico Tinarelli; Thierry Nieus; Andrea Raimondi; Barbara Greco; Daniela Cantatore; Laura Gasparini; Luca Berdondini; Angelo Bifone; Alessandro Gozzi; Sara Wells; Patrick M Nolan
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

7.  Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.

Authors:  Caroline F Wright; Tomas W Fitzgerald; Wendy D Jones; Stephen Clayton; Jeremy F McRae; Margriet van Kogelenberg; Daniel A King; Kirsty Ambridge; Daniel M Barrett; Tanya Bayzetinova; A Paul Bevan; Eugene Bragin; Eleni A Chatzimichali; Susan Gribble; Philip Jones; Netravathi Krishnappa; Laura E Mason; Ray Miller; Katherine I Morley; Vijaya Parthiban; Elena Prigmore; Diana Rajan; Alejandro Sifrim; G Jawahar Swaminathan; Adrian R Tivey; Anna Middleton; Michael Parker; Nigel P Carter; Jeffrey C Barrett; Matthew E Hurles; David R FitzPatrick; Helen V Firth
Journal:  Lancet       Date:  2014-12-17       Impact factor: 79.321

8.  A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.

Authors:  Anna Winczewska-Wiktor; Magdalena Badura-Stronka; Anna Monies-Nowicka; Michal Maciej Nowicki; Barbara Steinborn; Anna Latos-Bieleńska; Dorota Monies
Journal:  BMC Neurol       Date:  2016-03-12       Impact factor: 2.474

9.  Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects.

Authors:  Fengping Dong; Joanna Jiang; Colleen McSweeney; Donghua Zou; Long Liu; Yingwei Mao
Journal:  Hum Mol Genet       Date:  2016-04-30       Impact factor: 6.150

  9 in total
  14 in total

1.  Learning impairments and molecular changes in the brain caused by β-catenin loss.

Authors:  Robert J Wickham; Jonathan M Alexander; Lillian W Eden; Mabel Valencia-Yang; Josué Llamas; John R Aubrey; Michele H Jacob
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

2.  Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy.

Authors:  Andrés Moreno-De-Luca; Francisca Millan; Denis R Pesacreta; Houda Z Elloumi; Matthew T Oetjens; Claire Teigen; Karen E Wain; Julie Scuffins; Scott M Myers; Rebecca I Torene; Vladimir G Gainullin; Kevin Arvai; H Lester Kirchner; David H Ledbetter; Kyle Retterer; Christa L Martin
Journal:  JAMA       Date:  2021-02-02       Impact factor: 56.272

3.  A mouse model for kinesin family member 11 (Kif11)-associated familial exudative vitreoretinopathy.

Authors:  Yanshu Wang; Philip M Smallwood; John Williams; Jeremy Nathans
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

4.  Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.

Authors:  Justyna A Karolak; Przemyslaw Szafranski; David Kilner; Chirag Patel; Bonnie Scurry; Esther Kinning; Kate Chandler; Shalini N Jhangiani; Zeynep H Coban Akdemir; James R Lupski; Edwina Popek; Paweł Stankiewicz
Journal:  Clin Genet       Date:  2019-07-22       Impact factor: 4.438

5.  Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR.

Authors:  Evangelia S Panagiotou; Carla Sanjurjo Soriano; James A Poulter; Emma C Lord; Denisa Dzulova; Hiroyuki Kondo; Atsushi Hiyoshi; Brian Hon-Yin Chung; Yoyo Wing-Yiu Chu; Connie H Y Lai; Mark E Tafoya; Dyah Karjosukarso; Rob W J Collin; Joanne Topping; Louise M Downey; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

6.  The RNA helicase DDX3 induces neural crest by promoting AKT activity.

Authors:  Mark Perfetto; Xiaolu Xu; Congyu Lu; Yu Shi; Natasha Yousaf; Jiejing Li; Yvette Y Yien; Shuo Wei
Journal:  Development       Date:  2021-01-19       Impact factor: 6.862

Review 7.  Dissecting Molecular Genetic Mechanisms of 1q21.1 CNV in Neuropsychiatric Disorders.

Authors:  Joy Yoon; Yingwei Mao
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.

Authors:  Sheng Chih Jin; Sara A Lewis; Somayeh Bakhtiari; Xue Zeng; Michael C Sierant; Sheetal Shetty; Sandra M Nordlie; Aureliane Elie; Mark A Corbett; Bethany Y Norton; Clare L van Eyk; Shozeb Haider; Brandon S Guida; Helen Magee; James Liu; Stephen Pastore; John B Vincent; Janice Brunstrom-Hernandez; Antigone Papavasileiou; Michael C Fahey; Jesia G Berry; Kelly Harper; Chongchen Zhou; Junhui Zhang; Boyang Li; Hongyu Zhao; Jennifer Heim; Dani L Webber; Mahalia S B Frank; Lei Xia; Yiran Xu; Dengna Zhu; Bohao Zhang; Amar H Sheth; James R Knight; Christopher Castaldi; Irina R Tikhonova; Francesc López-Giráldez; Boris Keren; Sandra Whalen; Julien Buratti; Diane Doummar; Megan Cho; Kyle Retterer; Francisca Millan; Yangong Wang; Jeff L Waugh; Lance Rodan; Julie S Cohen; Ali Fatemi; Angela E Lin; John P Phillips; Timothy Feyma; Suzanna C MacLennan; Spencer Vaughan; Kylie E Crompton; Susan M Reid; Dinah S Reddihough; Qing Shang; Chao Gao; Iona Novak; Nadia Badawi; Yana A Wilson; Sarah J McIntyre; Shrikant M Mane; Xiaoyang Wang; David J Amor; Daniela C Zarnescu; Qiongshi Lu; Qinghe Xing; Changlian Zhu; Kaya Bilguvar; Sergio Padilla-Lopez; Richard P Lifton; Jozef Gecz; Alastair H MacLennan; Michael C Kruer
Journal:  Nat Genet       Date:  2020-09-28       Impact factor: 41.307

9.  The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders.

Authors:  Anastasia Levchenko; Innokentiy S Losenkov; Natalia M Vyalova; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Anton Jm Loonen; Svetlana A Ivanova
Journal:  Pharmgenomics Pers Med       Date:  2018-07-20

Review 10.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.